期刊文献+

老年患者铜绿假单胞菌感染的临床分布与耐药性分析 被引量:4

Clinical distribution and drug resistance Pseudomonas aeruginosa causing infections in senile patients
原文传递
导出
摘要 目的调查医院老年患者349株铜绿假单胞菌(PAE)感染的临床分布与耐药性,为临床医师控制感染提供参考依据。方法 349株铜绿假单胞菌的分离分纯和菌类鉴定遵循卫生部编写的《全国临床检验操作规程》(第3版)进行,药敏试验采用WHO规定的K-B法进行试验和读取数据。结果 349株铜绿假单胞菌在呼吸道标本中分布最高,占60.7%;其耐药率<15.0%的药物有阿米卡星、美罗培南、亚胺培南、头孢哌酮/舒巴坦、哌啦西林/他唑巴坦;耐药率>50.0%的抗菌药物有氨曲南、头孢噻肟、头孢吡肟、庆大霉素、环丙沙星。结论铜绿假单胞菌已表现出很高的抗药性,严重威胁老年患者的生命,医院应加强抗菌药物应用管理,提高临床医师抗菌药物处方水平,延缓细菌耐药性增长的不良趋势。 OBJECTIVE To investigate the clinical data and antimicrobial resistance profile of 349 Pseudomonas aeruginosa (PAE) isolates causing infections in senile patients so as to provide reference for the clinical control of infections. METHODS Bacterial culture and identification were performed according to National Guide to Clinical Laboratory Procedures (3rd revised). Drug susceptibility testing was performed with K-B methods specified by WHO. RESULTS The PAE strains were mainly isolated from respiratory tract specimens (60. 7%). The antibiotics with resistance rate less than 15. 0% included amikacin, meropenem, imipenem, cefoperazone- sulbactam and piperacillin-tazobatam. While aztreonam, cefotaxime, cefepime, gentamincin and ciprofloxacin showed resistance rate more than 50.0%. CONCLUSION The high drug resistance of PAE threatened the lives of senile patients. The hospital should strengthen the management of antibiotics and raise the clinicians capability of prescribing the antibiotics to postpone the increasing tendency of bacterial resistance.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第19期4799-4800,共2页 Chinese Journal of Nosocomiology
基金 武汉市卫生局基金(WX11B09)
关键词 老年患者 医院感染 铜绿假单胞菌 感染部位 耐药性 Senile patient Nosocomial infection Pseudomonas aeruginosa Infection site Antimicrobial resistance
  • 相关文献

参考文献6

二级参考文献21

共引文献218

同被引文献29

  • 1庞雪云,田碧文,蓝锴,孙蕾,黄宪章,李强.动态分析铜绿假单胞菌对亚胺培南的耐药性[J].现代检验医学杂志,2006,21(4):32-33. 被引量:1
  • 2谈华,邵海枫,王锦娜,王卫萍,李珍大.舒巴坦单剂及舒巴坦与第三代头孢菌素联合对鲍曼不动杆菌的体外抗菌作用比较[J].中国抗生素杂志,2006,31(8):488-491. 被引量:39
  • 3田德英,桂清荣,张振纲,许东,宋佩辉.老年感染患者病原菌分布及其耐药性监测[J].中华医院感染学杂志,2006,16(8):938-940. 被引量:17
  • 4Bendiak GN,Ratjen F. The approach to Pseudornonasaerug- inosa in cystic fibrosis [J]. Semin Respir Crit Care Med, 2009,30(5) : 587-595.
  • 5R0driguez-Martinez JM,Cano ME,Velaseo C,et al. Plasmid- mediated quinolone resistance: an update [J]. J Infect Che- mother,2011,17(2) :149-182.
  • 6LOnn-Stensrud J,Benneche T,Seheie AA. Bacterial interac- tions may be a key to future antibities[J]Lakartidningen, 2012,109(17-18) :879-881.
  • 7Giske CG, Buar L, Sundsfjord A, et al. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa[J]. Microb Drug Re- sist,2008,14(l) 23 30.
  • 8Kerr KG, Snelling AM. Pseudomonas aeruginosa., a formidable and every present adversary[J]. J Hosp Infect,2009,73(4) :338- 344.
  • 9Bendiak GN, Ratjen F. The approach to Pseudomonas ae- ruginosa in cystic fibrosis[J]. Semin Respir Crit Care Med,2009,30(5):587-595.
  • 10Rodriguez-Martinez JM, Cano ME, Velasco C, et al.Plas- midmediated quinolone resistance:an update[J]. J lnJect Chemother, 2011,17(2): 149-182.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部